Analyst Price Targets — GOCO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 26, 2025 11:32 am | Ben Hendrix | RBC Capital | $5.00 | $2.89 | StreetInsider | GoHealth Inc. (GOCO) PT Lowered to $5 at RBC Capital |
| August 28, 2025 12:52 pm | — | RBC Capital | $12.00 | $5.09 | TheFly | GoHealth price target raised to $12 from $8 at RBC Capital |
| March 20, 2024 6:50 am | Frank Morgan | RBC Capital | $13.00 | $10.16 | StreetInsider | GoHealth Inc. (GOCO) PT Lowered to $13 at RBC Capital, 'Weaker than expected results driven by lower volumes' |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for GOCO

GoHealth (GOCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Go Metals Corp. (CSE: GOCO) ("Go Metals" or the "Company") is pleased to report strong bench-scale metallurgical results from its 100%-owned KM98 vanadium titanomagnetite ("VTM") critical metals project in Quebec. The Company also announces the recent extension of its authorization for impact-causing exploration work (ATI) and related work permits for the…

Dallas, Texas--(Newsfile Corp. - April 16, 2026) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners Updates Coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth's 4Q25 results continued to reflect a Medicare Advantage environment shaped by tighter carrier discipline, with management prioritizing retention, member quality, and liquidity over volume.

LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises GoHealth , Inc. , (“ GoHealth " or the "Company") ( NASDAQ : GOCO ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

GoHealth (GOCO) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $2.69. This compares to earnings of $2.41 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GOCO.
U.S. House Trading
No House trades found for GOCO.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
